Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Business Roundup

March 12, 2007 | A version of this story appeared in Volume 85, Issue 11

Rhodia and SNIA have each sold their 50% stake in Nylstar for 1 euro—roughly $1.30—to a consortium of Nylstar's creditors. Rhodia says the agreement will give the beleaguered nylon-fiber producer a reduced debt load and a better chance of success.

Lanxess has opened a $5 million technology center in Pittsburgh. The center consolidates several North American labs for its rubber, material protection, and functional chemicals businesses.

Air Liquide is paying about $138 million to buy Linde's U.K. industrial gases business, which has annual sales of close to $80 million. Linde was required to sell the business as a condition of its 2006 acquisition of BOC.

Integrated Genomics has won a $70,000 Small Business Innovation Research contract from EPA. The company says the money will enable it to develop a method to make butanol from biomass that is economically competitive with the synthesis of butanol from petroleum.

Petrobras, Brazil's state oil company, won't confirm press reports that it is studying a potential petrochemical project in Peru based on natural gas from Peru's Camisea Basin. According to the reports, the project would make fertilizers and polyethylene and cost more than $2 billion.

Givaudan, the flavors and fragrances giant, has completed its acquisition of Quest International from ICI, after approvals were obtained in the U.S. and the European Union. The $2.3 billion deal was announced last November.

Peakdale Molecular has acquired nonexclusive rights to use Materia's metathesis technology to make research quantities of metathesis-based scaffolds for drug discovery. The two companies will jointly identify target compounds, and Peakdale will develop, produce, and distribute them.

PPD, a Morrisville, N.C., contract research company, has licensed the worldwide rights to develop, manufacture, and market a statin invented by India's Ranbaxy Laboratories. The drug is intended for the management of blood cholesterol levels.

Advertisement

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.